Repare Therapeutics' low P/S ratio is likely due to poor rev...
Repare Therapeutics' low P/S ratio is likely due to poor revenue performance and negative growth forecasts. The company's poor outlook compared to other industry players justifies its low P/S ratio.
Little Excitement Around Repare Therapeutics Inc.'s (NASDAQ:RPTX) Revenues As Shares Take 30% Pounding
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment